Our Publications
Research With Purpose
Support Our Work
Learn About Our Research
Serum Aβ Levels as Predictors of Conversion to Mild Cognitive Impairment/Alzheimer Disease in an ADAPT Subcohort
Molecular Medicine
Authors: Laila Abdullah, Cheryl Luis, Daniel Paris, Benoit Mouzon, Ghania Ait-Ghezala, Andrew P. Keegan, Duolao Wang, Fiona Crawford & Michael Mullan
Publish Date: August 18, 2009
Structural optimization of a CXCR2-directed antagonist that indirectly inhibits γ-secretase and reduces Aβ
Bioorganic & Medicinal Chemistry
Authors: Pancham Bakshi, Chao Jin, Pierre Broutin, Beniam Berhane, Jon Reed, Michael Mullan
Publish Date: December 1, 2009
Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer’s Aβ Peptide
International Journal of Peptide Research and Therapeutics
Authors: Daniel Paris, Nikunj Patel, Nowell J. Ganey, Vincent Laporte, Amita Quadros and Michael J. Mullan
Publish Date: January 19, 2010
Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer’s disease
Journal of Neuroinflammation
Authors: Daniel Paris, Nowell J Ganey, Vincent Laporte, Nikunj S Patel, David Beaulieu-Abdelahad, Corbin Bachmeier, Amelia March, Ghania Ait-Ghezala & Michael J Mullan
Publish Date: March 8, 2010
Apolipoprotein E Genotype and Oxidative Stress Response to Traumatic Brain Injury
Neurodegeneration, Neuroprotection and Disease-Oriented Neuroscience
Authors: S. Ferguson, B. Mouzon, G. Kayihan, M. Wood, F. Poon, S. Doore, V. Mathura, J. Humphrey, B. O'Steen, R. Hayes, A. Roses, M. Mullan, F. Crawford
Publish Date: July 14, 2010
Impaired Orthotopic Glioma Growth and Vascularization in Transgenic Mouse Models of Alzheimer’s Disease
The Journal of Neuroscience
Authors: Daniel Paris, Nowel Ganey, Magdalena Banasiak, Vincent Laporte, Nikunj Patel, Myles Mullan, Susan F. Murphy, Gi-Taek Yee, Corbin Bachmeier, Christopher Ganey, David Beaulieu-Abdelahad, Venkatarajan S. Mathura, Steven Brem and Michael Mullan
Publish Date: August 25, 2010
Demonstration of safety in Alzheimer’s patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study
International Journal of Geriatric Psychiatry
Authors: S. P. Kennelly, L. Abdullah, D. Paris, J. Parish, V. Mathura, M. Mullan, F. Crawford, B. A. Lawlor, R. A. Kenny
Publish Date: October 29, 2010
Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier
Molecular Medicine
Authors: Daniel Paris, Corbin Bachmeier, Nikunj Patel, Amita Quadros, Claude-Henry Volmar, Vincent Laporte, Jim Ganey, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, Fiona Crawford & Michael J. Mullan
Publish Date: December 18, 2010
Authors: Pancham Bakshi, Elaina Margenthaler, Jon Reed, Fiona Crawford, Michael Mullan
Publish Date: February 1, 2011
Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine
BIOPHARMACEUTICS & DRUG DISPOSITION
Authors: Corbin J. Bachmeier, David Beaulieu-Abdelahad, Nowell J. Ganey, Michael J. Mullan, Gary M. Levin
Publish Date: March 28, 2011
Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid
International Journal of Alzheimer’s Disease
Authors: Cheryl A. Luis, Laila Abdullah, Ghania Ait-Ghezala, Benoit Mouzon, Andrew P. Keegan, Fiona Crawford, Michael Mullan
Publish Date: May 24, 2011
Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood–brain barrier
European Journal of Pharmacology
Authors: Corbin Bachmeier, David Beaulieu-Abdelahad, Michael Mullan, Daniel Paris
Publish Date: June 1, 2011